NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 37 min ago
Notice of Correction to NOT-OD-22-109 - Inviting Comments and Suggestions on the Development of a Prize Competition for Institutional Excellence in Diversity, Equity, Inclusion, and Accessibility.
Notice NOT-OD-22-147 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Corrected Application Forms and Extended Receipt Date for PAR-22-076 "Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed)"
Notice NOT-NS-22-110 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Centers for Oceans and Human Health 4: Impacts of Climate Change on Oceans and Great Lakes (COHH4) (P01 Clinal Trial Optional)
Notice NOT-ES-22-011 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change of Application Due Date and Application Types Allowed for RFA-ES-22-004 "SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)"
Notice NOT-ES-22-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Joint NSF/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences
Notice NOT-GM-22-039 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIH Announces the Open Period of FY 2023 Helium-3 Requests for Medical Research
Notice NOT-HL-22-032 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NCI's Participation in Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)
Notice NOT-CA-22-101 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Additional Information for Funding Opportunity RFA-RM-22-020, NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Notice NOT-RM-22-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NHLBI Participation in NOT-OD-22-140 "Notice of Special Interest: Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence" (Admin Supp Clinical Trial Optional)
Notice NOT-HL-22-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to RFA-CA-22-022, "Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)"
Notice NOT-CA-22-090 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Salary Amounts for RFA-AG-23-016, "Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
Notice NOT-AG-22-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to PD(s/PI(s) Eligibility Requirements and Addition of Letter of Intent Deadline for PAR-19-362 Planning Grant for Global Infectious Disease Research Training Program (D71 - Clinical Trials Not Allowed)
Notice NOT-TW-22-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
Notice NOT-CA-22-088 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Expiration of RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
Notice NOT-HL-22-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
Funding Opportunity PAR-22-198 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal the PAIRS program is to the development of radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.
Categories: Job Watch, Literature Watch
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
Funding Opportunity PAR-22-199 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) will solicit R01 research projects that seek to investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.
Categories: Job Watch, Literature Watch
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-026 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support for the Center for International Blood and Marrow Transplant Research (CIBMTR) as a data resource enabling broad studies on Hematopoietic Stem Cell transplantation (HCT) and Adoptive Cellular Therapy (ACT) research. The CIBMTR represents a network comprised of more than 380 US and international transplant centers that submit outcome data for patients receiving cellular therapies. The CIBMTR Statistical Center provides data acquisition and management and information technology services to maintain a unique contemporary clinical outcomes' database and facilitates observational and interventional research through scientific and statistical expertise necessary to support analyses of these data. NIH is supporting the CIBMTR to ensure the database remains available to the public and to improve the treatment, survival, and quality of life for patients diagnosed with cancer and non-malignant blood disorders.
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Notice NOT-DA-22-070 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice to Extend RFA-MH-21-180, BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Notice NOT-MH-22-250 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-032 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish a network that will conduct transdisciplinary aging diagnostic biomarker and/or imaging research projects focused on Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) in persons living with Multiple Chronic Conditions (MCCs). The aim of the research is to better align diagnostic testing with the needs and priorities of an aging population. The national consortium will: 1) assemble existing data and acquire real-world data to ensure that the research sample is large and diverse, with adequate representation of older adults living with well-characterized MCCs, and incorporate pre-specified subgroup analyses; 2) analyze data for performance and accuracy of biomarkers, to include blood, cerebrospinal fluid (CSF), and imaging, in older patients living with MCCs; and 3) conduct pilot studies involving specific AD/ADRD imaging and/or biomarkers in persons living with MCCs.
Categories: Job Watch, Literature Watch